X0306 4 2015-11-02 1 0000815065 STERIS CORP STE 0001578804 Zangerle John Adam C/O 5960 HEISLEY ROAD MENTOR OH 44060 0 1 0 0 VP, Gen Counsel, and Sec. Common Shares, No Par Value 2015-11-02 4 D 0 18608 D 0 D Employee Stock Option (right to buy) 27.68 2015-11-02 4 D 0 2200 D 2017-07-27 Common Shares, No Par Value 2200 0 D Employee Stock Option (right to buy) 30.84 2015-11-02 4 D 0 3100 D 2018-05-21 Common Shares, No Par Value 3100 0 D Employee Stock Option (right to buy) 22.83 2015-11-02 4 D 0 3150 D 2019-05-21 Common Shares, No Par Value 3150 0 D Employee Stock Option (right to buy) 31.87 2015-11-02 4 D 0 3000 D 2020-05-20 Common Shares, No Par Value 3000 0 D Employee Stock Option (right to buy) 36.09 2015-11-02 4 D 0 3500 D 2021-05-31 Common Shares, No Par Value 3500 0 D Employee Stock Option (right to buy) 29.94 2015-11-02 4 D 0 3800 D 2022-05-30 Common Shares, No Par Value 3800 0 D Employee Stock Option (right to buy) 45.34 2015-11-02 4 D 0 6000 D 2023-05-31 Common Shares, No Par Value 6000 0 D Employee Stock Option (right to buy) 53.52 2015-11-02 4 D 0 12252 D 2024-05-30 Common Shares, No Par Value 12252 0 D Employee Stock Option (right to buy) 67.98 2015-11-02 4 D 0 8000 D 2025-08-10 Common Shares, No Par Value 8000 0 D 13,652 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 1,400 on May 31, 2016; 1,000 on August 1, 2016; 1,000 on November 28, 2016; 5,000 on May 31, 2017; 2,252 on May 30, 2018; and 3,000 on May 28, 2019. Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 2,200 ordinary shares of New STERIS for $27.68 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,100 ordinary shares of New STERIS for $30.84 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,150 ordinary shares of New STERIS for $22.83 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,000 ordinary shares of New STERIS for $31.87 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,500 ordinary shares of New STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 950 on May 30, 2016. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,800 ordinary shares of New STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 1,500 on May 31, 2016 and 1,500 on May 31, 2017. This option was assumed by New STERIS in the Merger and converted to an option to purchase 6,000 ordinary shares of New STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 3,063 on May 30, 2016; 3,063 on May 30, 2017 and 3,063 on May 30, 2018. This option was assumed by New STERIS in the Merger and converted to an option to purchase 12,252 ordinary shares of New STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by New STERIS in the Merger and converted to an option to purchase 8,000 ordinary shares of New STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original STERIS option. /s/ Dennis P. Patton, Authorized Representative under Power of Attorney 2015-11-02